Morgan Stanley’s P3 Health Partners PIII Stock Holding History
Bought
Maintained
Sold
Other funds holding PIII
Morgan Stanley's PIII Position: Q3 2026 in Review
Morgan Stanley increased its P3 Health Partners (PIII) stake by 276% in Q3 2026, buying an estimated $74.9K and bringing the position to 10,605 shares worth $71.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6442.
Morgan Stanley first reported a position in PIII in Q2 2021 and has held it in 16 quarters since. The position peaked at $736K in Q3 2024. 17 funds tracked by Wall St. Rank hold PIII as of Q3 2026.
- Morgan Stanley held 10,605 shares of P3 Health Partners worth $71.7K as of Q3 2026.
- Morgan Stanley bought 7,785 P3 Health Partners shares in Q3 2026, an estimated $74.9K.
- P3 Health Partners made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #6442 holding.
- Morgan Stanley first reported a position in P3 Health Partners in Q2 2021 and has held it in 16 quarters since.
- Morgan Stanley's P3 Health Partners position peaked at $736K in Q3 2024.
- 17 funds tracked by Wall St. Rank held P3 Health Partners as of Q3 2026.
Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.